[embedded content] [The stream is slated to start at 10 a.m. ET. Please refresh the page if you do not see a player above at that time.] The U.S. House of Representatives Oversight and Reform Committee is holding a hearing Wednesday with current and former executives of three major drug companies on the high cost… Read More: Watch live: Pharma executives testify at House hearing on drug… »
Many times through the years, HealthNewsReview.org has criticized the National Press Foundation in Washington, DC, for accepting drug company funding for journalism training. (See articles from June 2009, July 2009, August 2010, September 2010, October 2010, March 2014, March 2015, December 2015, November 2019. I may have missed a few, but you get the picture.) They’re doing it… Read More: Drug company influence on journalism »
Print this page HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] Tremfya is the first treatment… Read More: Tremfya (guselkumab) Approved by U.S. Food and Drug Administration as… »
The hopeful buzz around the drug Remdesivir and its potential as a COVID-19 treatment was so deafening Wednesday, it triggered an unexpected surge in the financial markets. New evidence “has proven … that a drug can block this virus,” enthused Dr. Anthony Fauci, the U.S. government’s top infectious disease expert. But Canadian experts were not… Read More: More data, supply needed before making promising COVID-19 drug Remdesivir… »